The of effects of newly developed long-chain amylopectin-containing-rice,Konayukinomai,and its processed products on postprandial glucose level.Long-team trial

The of effects of newly developed long-chain amylopectin-containing-rice,Konayukinomai,and its processed products on postprandial glucose level.Long-team trial - Long-team trial on the developed long-chain amylopectin-containing-rice

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000015252

Enrollment

Registered

2014-09-25

Start date

2014-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Syndrome Initial Diabetes

Interventions

Konayukinomai as a steam rice per 200g once a day for 3 months Kosihikari as a steam rice per 200g once a day for 3 months

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Viceral fat area<100cm2 HbA1c<8.0%

Exclusion criteria

Exclusion criteria: Exsist hepatic failure or renal disease Food Allergy The person who was disqualified by a docotor

Design outcomes

Primary

Measure	Time frame
Blood glucose level of the day Visceral fat area	—

Secondary

Measure	Time frame
HbA1c,insuline,food intake	—

Countries

Japan

Contacts

Public ContactKeiko Kamachi

Kagawa Nutrition University Nutrition Clinic

kamachi@eiyo.ac.jp03-3918-6181

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026